PL2040672T3 - Ciekłe kompozycje fenylefryny o podwyższonej stabilności - Google Patents

Ciekłe kompozycje fenylefryny o podwyższonej stabilności

Info

Publication number
PL2040672T3
PL2040672T3 PL07836046T PL07836046T PL2040672T3 PL 2040672 T3 PL2040672 T3 PL 2040672T3 PL 07836046 T PL07836046 T PL 07836046T PL 07836046 T PL07836046 T PL 07836046T PL 2040672 T3 PL2040672 T3 PL 2040672T3
Authority
PL
Poland
Prior art keywords
liquid compositions
enhanced stability
phenylephrine liquid
stability phenylephrine
enhanced
Prior art date
Application number
PL07836046T
Other languages
English (en)
Inventor
William Bubnis
Stephanie Shield
Gayle P Hoskovec
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38814551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2040672(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL2040672T3 publication Critical patent/PL2040672T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07836046T 2006-07-14 2007-07-11 Ciekłe kompozycje fenylefryny o podwyższonej stabilności PL2040672T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/487,120 US20080014274A1 (en) 2006-07-14 2006-07-14 Enhanced stability phenylephrine liquid compositions
EP07836046.8A EP2040672B1 (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions
PCT/US2007/015771 WO2008008364A2 (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions

Publications (1)

Publication Number Publication Date
PL2040672T3 true PL2040672T3 (pl) 2015-07-31

Family

ID=38814551

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11163553T PL2351554T3 (pl) 2006-07-14 2007-07-11 Płynne kompozycje fenylefryny o zwiększonej stabilności
PL07836046T PL2040672T3 (pl) 2006-07-14 2007-07-11 Ciekłe kompozycje fenylefryny o podwyższonej stabilności

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL11163553T PL2351554T3 (pl) 2006-07-14 2007-07-11 Płynne kompozycje fenylefryny o zwiększonej stabilności

Country Status (26)

Country Link
US (1) US20080014274A1 (pl)
EP (2) EP2351554B1 (pl)
JP (1) JP2009543777A (pl)
KR (2) KR20090040334A (pl)
CN (2) CN104546671A (pl)
AR (1) AR061985A1 (pl)
AU (1) AU2007272961B2 (pl)
BR (1) BRPI0714399B8 (pl)
CA (1) CA2657611A1 (pl)
CO (1) CO6180496A2 (pl)
EC (1) ECSP099072A (pl)
ES (2) ES2550036T3 (pl)
HK (1) HK1205933A1 (pl)
HU (2) HUE025694T2 (pl)
IL (1) IL196447A (pl)
MX (1) MX2009000530A (pl)
NZ (1) NZ574148A (pl)
PE (1) PE20081003A1 (pl)
PL (2) PL2351554T3 (pl)
PT (2) PT2351554E (pl)
RU (1) RU2468787C2 (pl)
SG (2) SG173354A1 (pl)
TW (1) TW200812640A (pl)
UY (1) UY30484A1 (pl)
WO (1) WO2008008364A2 (pl)
ZA (1) ZA200900315B (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
CN101472561A (zh) * 2006-06-01 2009-07-01 先灵公司 去氧肾上腺素脉冲释放制剂和药物组合物
MX2008015358A (es) * 2006-06-01 2009-03-06 Schering Corp Composiciones farmaceuticas para liberacion sostenida de fenilefrina.
CA2653953C (en) * 2006-06-01 2015-12-08 Schering-Plough Healthcare Products, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
CA2697959A1 (en) * 2007-06-01 2008-12-11 Schering-Plough Healthcare Products, Inc. Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2802362C (en) * 2010-06-11 2017-11-21 Gm Pharmaceuticals, Inc. Pharmaceutical compositions for alleviating upper respiratory and oral-pharyngeal congestion
HUE045889T2 (hu) 2010-10-21 2020-01-28 Rtu Pharmaceuticals Llc Használatkész ketorolak készítmények
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
NZ709958A (en) * 2013-02-28 2018-03-23 Pfizer Enhanced stability of novel liquid compositions
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
JP5918895B1 (ja) * 2015-05-21 2016-05-18 富士カプセル株式会社 ナルフラフィン塩酸塩含有カプセル製剤
JP2018516279A (ja) * 2015-05-29 2018-06-21 コーダドース・インコーポレーテッド 経口投与用のセレコキシブの液状配合物
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
US20180055938A1 (en) * 2016-09-01 2018-03-01 The Procter & Gamble Company Medication With Improved Taste And Sensory Experience
BR112019005224A2 (pt) 2016-09-26 2019-06-11 The Procter & Gamble Company forma de dosagem para alívio prolongado
CN110115708A (zh) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 乙酰胺酚及曲马多共溶复方止痛口服液
CR20200552A (es) 2018-05-16 2021-05-13 Bayer Healthcare Llc Fórmula de suspención de alta concentración para medicamentos en cápsula de gel blanda paae resfriado y gripe
CN108434097A (zh) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 一种稳定的含盐酸曲普利啶口服溶液剂及其制备方法
CN109010341A (zh) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 一种含有氢溴酸右美沙芬的复方口服溶液及其制备方法
SG11202111251SA (en) 2019-04-11 2021-11-29 R P Scherer Technologies Llc Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
RS65089B1 (sr) 2019-12-23 2024-02-29 Nutra Essential Otc S L Tečna kompozicija koja sadrži ibuprofen i fenilefrin
WO2021150747A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine hydrochloride compositions and containers
CN111773203B (zh) * 2020-05-15 2024-11-26 北京博智绿洲医药科技有限公司 一种包含盐酸去氧肾上腺素组合物的制备工艺
CN111803452B (zh) * 2020-07-08 2026-02-06 北京博智绿洲医药科技有限公司 一种包含盐酸去氧肾上腺素组合物的泡腾颗粒剂制备工艺
CN114533664B (zh) * 2022-01-29 2023-03-31 江苏广承药业有限公司 一种氢溴酸右美沙芬和愈创木酚甘油醚复方口服液体制剂
WO2026015096A1 (en) * 2024-07-09 2026-01-15 Humanis Sağlik A.Ş. Paraben free syrup compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5759579A (en) 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE69815003T2 (de) * 1997-09-10 2004-04-01 Takeda Chemical Industries, Ltd. Stabilisierte pharmazeutische Zusammensetzung
US6287597B1 (en) 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
EP1411955A4 (en) 2001-07-31 2006-07-05 Wyeth Corp SUCRALOSE FORMULATIONS FOR COVERING UNANGEAN TASTE
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20040132827A1 (en) 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
AU2003301654A1 (en) * 2002-10-22 2004-05-13 Dainippon Pharmaceutical Co., Ltd. Stabilized composition
US6979689B2 (en) 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
JP2004300138A (ja) * 2003-03-18 2004-10-28 Takeda Chem Ind Ltd 安定化された経口固形製剤
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
DE10358213A1 (de) 2003-12-12 2005-07-28 Clariant Gmbh Polyethylenglykol und dessen Herstellung
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness

Also Published As

Publication number Publication date
IL196447A0 (en) 2009-09-22
RU2468787C2 (ru) 2012-12-10
NZ574148A (en) 2012-07-27
BRPI0714399B1 (pt) 2020-11-17
KR20140088234A (ko) 2014-07-09
WO2008008364A2 (en) 2008-01-17
ES2550036T3 (es) 2015-11-04
TW200812640A (en) 2008-03-16
SG173354A1 (en) 2011-08-29
BRPI0714399B8 (pt) 2021-05-25
EP2040672B1 (en) 2015-04-01
RU2009101295A (ru) 2010-08-27
CA2657611A1 (en) 2008-01-17
EP2351554B1 (en) 2015-09-09
SG10201408522UA (en) 2015-02-27
CN101500539A (zh) 2009-08-05
PT2040672E (pt) 2015-07-02
PL2351554T3 (pl) 2016-01-29
UY30484A1 (es) 2008-02-29
CO6180496A2 (es) 2010-07-19
AR061985A1 (es) 2008-08-10
HUE025694T2 (hu) 2016-04-28
WO2008008364A3 (en) 2008-05-22
EP2351554A1 (en) 2011-08-03
PT2351554E (pt) 2015-11-02
KR20090040334A (ko) 2009-04-23
HK1205933A1 (en) 2015-12-31
ZA200900315B (en) 2009-12-30
EP2040672A2 (en) 2009-04-01
HK1128886A1 (en) 2009-11-13
MX2009000530A (es) 2009-01-27
CN104546671A (zh) 2015-04-29
BRPI0714399A2 (pt) 2013-03-12
IL196447A (en) 2015-06-30
ECSP099072A (es) 2009-02-27
HUE025790T2 (hu) 2016-05-30
AU2007272961B2 (en) 2011-07-28
JP2009543777A (ja) 2009-12-10
ES2537761T3 (es) 2015-06-11
AU2007272961A1 (en) 2008-01-17
US20080014274A1 (en) 2008-01-17
PE20081003A1 (es) 2008-07-13

Similar Documents

Publication Publication Date Title
SG10201408522UA (en) Enhanced stability phenylephrine liquid compositions
SI1984009T1 (sl) Farmacevtski sestavki z izboljĺ ano stabilnostjo
GB2463582B (en) Functional fluid compositions
EP2001498A4 (en) PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
GB0623838D0 (en) Novel compositions
PL3329912T3 (pl) Ciekła kompozycja
SI2124556T1 (sl) Farmacevtske sestave
GB0625069D0 (en) Compositions
GB0607085D0 (en) Novel compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
GB0620279D0 (en) Compositions
GB0610322D0 (en) Novel pharmaceutical compositions
IL206487A0 (en) Pharmaceutical compositions
GB0618657D0 (en) Compositions
GB0620918D0 (en) Compositions
GB0601899D0 (en) Compositions
GB0917779D0 (en) Novel compositions
GB0611033D0 (en) Compositions
GB0616336D0 (en) Fluid composition
GB0620204D0 (en) Compositions
GB0621751D0 (en) Compositions
GB0622456D0 (en) Compositions
GB0621950D0 (en) Compositions